Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Cash from Investing Activities (2023 - 2025)

Ardent Health (ARDT) has 3 years of Cash from Investing Activities data on record, last reported at -$58.6 million in Q3 2025.

  • For Q3 2025, Cash from Investing Activities fell 31.73% year-over-year to -$58.6 million; the TTM value through Sep 2025 reached -$233.4 million, down 35.94%, while the annual FY2024 figure was -$220.5 million, 59.77% down from the prior year.
  • Cash from Investing Activities reached -$58.6 million in Q3 2025 per ARDT's latest filing, down from -$46.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$23.1 million in Q1 2025 and bottomed at -$105.4 million in Q4 2024.
  • Average Cash from Investing Activities over 3 years is -$47.8 million, with a median of -$44.5 million recorded in 2024.
  • Peak YoY movement for Cash from Investing Activities: plummeted 85.95% in 2024, then grew 26.92% in 2025.
  • A 3-year view of Cash from Investing Activities shows it stood at -$56.7 million in 2023, then plummeted by 85.95% to -$105.4 million in 2024, then skyrocketed by 44.4% to -$58.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$58.6 million in Q3 2025, -$46.2 million in Q2 2025, and -$23.1 million in Q1 2025.